Volume 24, Issue 3 | American Journal of Cardiovascular Drugs

Search all American Journal of Cardiovascular Drugs articles

Volume 24, Issue 3

May 2024

Filter by

Volume:

Sort by

Date published:

New to old Old to new

12 articles in this issue

Advancing Guideline-Directed Medical Therapy in Heart Failure: Overcoming Challenges and Maximizing Benefits
Zixi Zhang
Cancan Wang
Qiming Liu
Review Article Open access 03 April 2024 Pages: 329 - 342
Drug Therapy for Acute and Chronic Heart Failure with Preserved Ejection Fraction with Hypertension: A State-of-the-Art Review
Hiroaki Hiraiwa
Takahiro Okumura
Toyoaki Murohara
Review Article Open access 04 April 2024 Pages: 343 - 369
Evaluation of the Lifetime Benefits of Metformin and SGLT2 Inhibitors in Type 2 Diabetes Mellitus Patients with Cardiovascular Disease: A Systematic Review and Two-Stage Meta-Analysis
Hon Jen Wong
Norman H. Lin
Ching-Hui Sia
Systematic Review 08 April 2024 Pages: 371 - 383
Differential Use of Glycoprotein IIb/IIIa Inhibitors with Bivalirudin in Patients with STEMI Undergoing PCI: A Systematic Review and Meta-Analysis
Hasan Mushahid
Syeda Ayesha Shah
Muhammad Shariq Usman
Systematic Review 29 April 2024 Pages: 385 - 398
Digoxin is Not Related to Mortality in Patients with Heart Failure: Results from the SELFIE-TR Registry
Rengin Çetin Güvenç
Tolga Sinan Güvenç
Mehmet Birhan Yılmaz
Original Research Article 04 April 2024 Pages: 399 - 408
Treatment Patterns, Outcomes, and Persistence to Newly Started Heart Failure Medications in Patients with Worsening Heart Failure: A Cohort Study from the United States and Germany
Alexander Michel
Coralie Lecomte
Thomas Evers
Original Research Article 04 April 2024 Pages: 409 - 418
Comparative Safety and Efficacy of Low/Moderate-Intensity Statin plus Ezetimibe Combination Therapy vs. High-Intensity Statin Monotherapy in Patients with Atherosclerotic Cardiovascular Disease: An Updated Meta-Analysis
Ishaque Hameed
Syeda Ayesha Shah
Mohammad Hamza
Original Research Article 05 April 2024 Pages: 419 - 431
Trends in Oral Anticoagulant Use and Individual Expenditures Across the United States from 2014 to 2020
Omar S. Alkhezi
Leo F. Buckley
John Fanikos
Original Research Article 07 April 2024 Pages: 433 - 444
Cost–Utility Analysis of Vericiguat in Heart Failure with Reduced Ejection Fraction After Worsening Heart Failure Events in China
Penglei Chen
Yixiang Wang
Xuwei Zheng
Original Research Article 15 April 2024 Pages: 445 - 454
Comparative Genitourinary Safety of In-class Sodium-Glucose Cotransporter-2 Inhibitors among Patients with Heart Failure with Preserved Ejection Fraction: A Cohort Study
Munaza Riaz
Jingchuan Guo
Haesuk Park
Original Research Article 30 April 2024 Pages: 455 - 464
Comment on: “Aspirin for the Primary Prevention of Cardiovascular Diseases in Patients with Chronic Kidney Disease: An Updated Meta-analysis”
Hussain Sohail Rangwala
Hareer Fatima
Burhanuddin Sohail Rangwala
Letter to the Editor 02 April 2024 Pages: 465 - 466
Authors’ Reply to Rangwala et al: “Aspirin for the Primary Prevention of Cardiovascular Diseases in Patients with Chronic Kidney Disease: An Updated Meta-analysis”
Ioannis Bellos
Smaragdi Marinaki
Vassiliki Benetou
Letter to the Editor 04 April 2024 Pages: 467 - 468